| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Pathology, Gifu University School of Medicine, Gifu 500-8705, Japan
Activating mutations in the ß-catenin gene is thought to be responsible for the excessive ß-catenin signaling involved in the majority of carcinogen-induced colonic carcinomas. To determine whether ß-catenin signaling is involved in the initial stage of colon carcinogenesis, mutational analysis of the gene and immunohistochemistry for ß-catenin protein were performed in the early appearing lesions, including aberrant crypt foci (ACF), of colonic mucosa in rats given azoxymethane. Male F344 rats received s.c. injections of azoxymethane at a dose of 15 mg/kg body weight, once weekly for 3 weeks, and they were sacrificed 10 weeks after the carcinogen treatment. The colonic mucosa was examined in en face preparations and in serial sections after the observation in whole mount preparations. Microscopical observations in the cross sections have shown two populations of histologically altered crypts. The first type had a macroscopic feature resembling ACF [histologically altered crypts with ACF appearance (HACAs)]. The second type of altered crypts did not have the ACF-like appearance and could not be clearly distinguished from adjacent normal crypts in whole mount preparations [histologically altered crypts with macroscopically normal-like appearance (HACNs)]. The ß-catenin gene mutations were recognized in 10 of 15 HACNs (67%) and 3 of 15 HACAs (20%). Frequent immunoreactivity of ß-catenin protein was seen in the cytoplasm of HACNs (13 of 15 cases), whereas apparent accumulation was not confirmed in any HACAs analyzed. These results suggest that (a) there are two types of putative preneoplastic lesions in cancer-predisposed colonic mucosa, and ß-catenin signaling may contribute to the initial stage of colon carcinogenesis; and (b) HACNs are more likely to be direct precursors of colon tumors than HACAs in the rat colon carcinogenesis.
This article has been cited by other articles:
![]() |
L. A. Davidson, N. Wang, I. Ivanov, J. Goldsby, J. R. Lupton, and R. S. Chapkin Identification of Actively Translated mRNA Transcripts in a Rat Model of Early-Stage Colon Carcinogenesis Cancer Prevention Research, November 1, 2009; 2(11): 984 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, X. Wang, W. Gong, B. Mi, S. Liu, and B. Jiang Increased Expression of {beta}-Catenin, Phosphorylated Glycogen Synthase Kinase 3{beta}, Cyclin D1, and c-myc in Laterally Spreading Colorectal Tumors J. Histochem. Cytochem., April 1, 2009; 57(4): 363 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Rosenberg, C. Giardina, and T. Tanaka Mouse models for the study of colon carcinogenesis Carcinogenesis, February 1, 2009; 30(2): 183 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Raufman, R. Samimi, N. Shah, S. Khurana, J. Shant, C. Drachenberg, G. Xie, J. Wess, and K. Cheng Genetic Ablation of M3 Muscarinic Receptors Attenuates Murine Colon Epithelial Cell Proliferation and Neoplasia Cancer Res., May 15, 2008; 68(10): 3573 - 3578. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kim, J. Ng, A. Arozulllah, R. Ewing, X. Llor, R. E. Carroll, and R. V. Benya Aberrant Crypt Focus Size Predicts Distal Polyp Histopathology Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1155 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Cho, T. Imai, Y. Ota, M. Hasumura, S. Takami, M. Hirose, and A. Nishikawa A New Medium-term Rat Colorectal Bioassay Applying Neoplastic Lesions as End Points for Detection of Carcinogenesis Modifiers Effects with Weak or Controversial Modifiers Toxicol Pathol, April 1, 2008; 36(3): 459 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imai, K. Fukuta, M. Hasumura, Y.-M. Cho, Y. Ota, S. Takami, H. Nakagama, and M. Hirose Significance of inflammation-associated regenerative mucosa characterized by Paneth cell metaplasia and {beta}-catenin accumulation for the onset of colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine Carcinogenesis, October 1, 2007; 28(10): 2199 - 2206. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. K. Glebov, L. M. Rodriguez, P. Soballe, J. DeNobile, J. Cliatt, K. Nakahara, and I. R. Kirsch Gene Expression Patterns Distinguish Colonoscopically Isolated Human Aberrant Crypt Foci from Normal Colonic Mucosa. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2253 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Katsuki, K. Hirata, H. Ishikawa, N. Matsuura, S.-i. Sumi, and H. Itoh Aged Garlic Extract Has Chemopreventative Effects On 1,2-Dimethylhydrazine-Induced Colon Tumors in Rats J. Nutr., March 1, 2006; 136(3): 847S - 851S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y.A. Plate and D. D. Gallaher Effects of Indole-3-Carbinol and phenethyl isothiocyanate on colon carcinogenesis induced by azoxymethane in rats Carcinogenesis, February 1, 2006; 27(2): 287 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ju, J. Hong, J.-n. Zhou, Z. Pan, M. Bose, J. Liao, G.-y. Yang, Y. Y. Liu, Z. Hou, Y. Lin, et al. Inhibition of Intestinal Tumorigenesis in Apcmin/+ Mice by (-)-Epigallocatechin-3-Gallate, the Major Catechin in Green Tea Cancer Res., November 15, 2005; 65(22): 10623 - 10631. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Paulsen, E. M. Loberg, H. B. Olstorn, H. Knutsen, I.-L. Steffensen, and J. Alexander Flat Dysplastic Aberrant Crypt Foci Are Related to Tumorigenesis in the Colon of Azoxymethane-Treated Rat Cancer Res., January 1, 2005; 65(1): 121 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Hull, S. C.W. Ko, and G. Hawcroft Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer? Mol. Cancer Ther., August 1, 2004; 3(8): 1031 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Femia, P. Dolara, and G. Caderni Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis Carcinogenesis, February 1, 2004; 25(2): 277 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ochiai, M. Ushigome, K. Fujiwara, T. Ubagai, T. Kawamori, T. Sugimura, M. Nagao, and H. Nakagama Characterization of Dysplastic Aberrant Crypt Foci in the Rat Colon Induced by 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Am. J. Pathol., October 1, 2003; 163(4): 1607 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamada and H. Mori Pre-cancerous lesions for colorectal cancers in rodents: a new concept Carcinogenesis, June 1, 2003; 24(6): 1015 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Caderni, A. P. Femia, A. Giannini, A. Favuzza, C. Luceri, M. Salvadori, and P. Dolara Identification of Mucin-depleted Foci in the Unsectioned Colon of Azoxymethane-treated Rats: Correlation with Carcinogenesis Cancer Res., May 15, 2003; 63(10): 2388 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamada, T. Oyama, Y. Hirose, A. Hara, S. Sugie, K. Yoshida, N. Yoshimi, and H. Mori {beta}-Catenin mutation is selected during malignant transformation in colon carcinogenesis Carcinogenesis, January 1, 2003; 24(1): 91 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hirose, T. Kuno, Y. Yamada, K. Sakata, M. Katayama, K. Yoshida, Z. Qiao, K. Hata, N. Yoshimi, and H. Mori Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis Carcinogenesis, January 1, 2003; 24(1): 107 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Wali, S. Khare, M. Tretiakova, G. Cohen, L. Nguyen, J. Hart, J. Wang, M. Wen, A. Ramaswamy, L. Joseph, et al. Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer: Roles of Cyclin D1 and E-Cadherin Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1653 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamada, K. Hata, Y. Hirose, A. Hara, S. Sugie, T. Kuno, N. Yoshimi, T. Tanaka, and H. Mori Microadenomatous Lesions Involving Loss of Apc Heterozygosity in the Colon of Adult ApcMin/+ Mice Cancer Res., November 15, 2002; 62(22): 6367 - 6370. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Caderni, M.-G. Perrelli, F. Cecchini, and L. Tessitore Enhanced growth of colorectal aberrant crypt foci in fasted/refed rats involves changes in TGF{beta}1 and p21CIP expressions Carcinogenesis, February 1, 2002; 23(2): 323 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. P. Hao, T. G. Pretlow, J. S. Rao, and T. P. Pretlow {beta}-Catenin Expression Is Altered in Human Colonic Aberrant Crypt Foci Cancer Res., November 1, 2001; 61(22): 8085 - 8088. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Pretlow, R. P. Bird, Y. Yamada, Y. Hirose, A. Hara, and H. Mori Correspondence re: Y. Yamada et al., Frequent {beta}-Catenin Gene Mutations and Accumulations of the Protein in the Putative Preneoplastic Lesions Lacking Macroscopic Aberrant Crypt Foci Appearance, In Rat Colon Carcinogenesis. Cancer Res., 60: 3323-3327, 2000; and Sequential Analysis of Morphological and Biological Properties of {beta}-Catenin-accumulated Crypts, Provable Premalignant Lesions Independent of Aberrant Crypt Foci in Rat Colon Carcinogenesis. Cancer Res., 61: 1874-1878, 2001. Cancer Res., October 1, 2001; 61(20): 7699 - 7701. [Full Text] [PDF] |
||||
![]() |
J. Erik Paulsen, I.-L. Steffensen, E. M. Loberg, T. Husoy, E. Namork, and J. Alexander Qualitative and Quantitative Relationship between Dysplastic Aberrant Crypt Foci and Tumorigenesis in the Min/+ Mouse Colon Cancer Res., July 1, 2001; 61(13): 5010 - 5015. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamada, N. Yoshimi, Y. Hirose, K. Matsunaga, M. Katayama, K. Sakata, M. Shimizu, T. Kuno, and H. Mori Sequential Analysis of Morphological and Biological Properties of {beta}-Catenin-accumulated Crypts, Provable Premalignant Lesions Independent of Aberrant Crypt Foci in Rat Colon Carcinogenesis Cancer Res., March 1, 2001; 61(5): 1874 - 1878. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |